MENU
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prelude Therapeutics (PRLD) Earnings Date & Reports

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs... Show more

A.I. Advisor
published Earnings

PRLD is expected to report earnings to rise 14.86% to -42 cents per share on May 13

Prelude Therapeutics PRLD Stock Earnings Reports
Q1'25
Est.
$-0.43
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.07
The last earnings report on March 10 showed earnings per share of -37 cents, beating the estimate of -47 cents. With 154.63K shares outstanding, the current market capitalization sits at 39.05M.
View a ticker or compare two or three
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com